Navigation Links
Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results
Date:10/14/2008

SOMERSET, N.J., Oct. 14 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today reported its financial results for the fourth quarter and fiscal year ended July 31, 2008.

The company recorded a net loss of approximately $2.9 million, or $0.06 per basic and diluted common share, for the fourth fiscal quarter ended July 31, compared to a net loss of approximately $2.4 million, or $0.05 per basic and diluted common share, for the fourth quarter of fiscal 2007. Research and development expenses increased by approximately $0.9 million during the fourth quarter of fiscal 2008 as compared to the same quarter a year ago primarily due to expenses incurred related to the company's preparations for the completion of its ONCONASE(R) rolling New Drug Application (NDA) submission. Decreased general and administrative expenses of approximately $0.5 million for the fourth quarter of fiscal 2008 were primarily the result of reduced stock based compensation expenses.

Net loss for the fiscal year ended July 31, 2008 of approximately $12.3 million, or $0.26 per basic and diluted common share, represents an increase of approximately $3.5 million, compared to the $8.8 million net loss, or $0.19 per basic and diluted common share, for fiscal 2007.

Cash and Liquidity

As of July 31, 2008, the company had cash and cash equivalents of approximately $4.7 million, a decrease of approximately $3.1 million, compared to cash and cash equivalents of approximately $7.8 million on April 30, 2008. The company has received notification that it continues to qualify for the sale of its state tax loss carryforwards in New Jersey and is awaiting additional information on the proceeds it can expect to receive from this sale in late 2008
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Paper in Cell Cycle Reports Alfacells ONCONASE(R) Targets siRNA
2. Alfacell Hires Advisors to Advance Strategic Alternatives
3. Alfacell Receives NASDAQ Delisting Letter
4. Alfacell Receives NASDAQ Non-Compliance Notification
5. Alfacell Reports Financial Results for Third Quarter of Fiscal 2008
6. Alfacell Announces Retirement of Chief Executive Officer
7. Alfacell Reports Financial Results for Second Quarter of Fiscal 2008
8. Alfacell to Host Fiscal Second Quarter 2008 Financial Results Conference Call and Webcast
9. Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories
10. Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29
11. Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Philadelphia’s newest entrepreneurial incubation space is ready for business, ... Innovation Center @3401 , a collaborative effort of Drexel ... to help attract and nurture start-up businesses in the region, ... , The Innovation Center @3401 (ic@3401), which is located ... new home of DreamIt Ventures and Point.io ...
(Date:7/29/2014)... July 29, 2014  Sigma-Aldrich Corporation (NASDAQ: ... use, increased its investment in Green Chemistry and donated ... world last year, the Company announced Monday in its ... Changed the World? The report comes ... for being a responsible corporate citizen, including recognition for ...
(Date:7/29/2014)... Quorum Review IRB, the industry ... accreditation by the International Association of Six ... Sigma Deployment Program. The citation recognizes robust organizational ... Quorum’s Lean Six Sigma program was evaluated by ... The designation is a public statement of excellence ...
(Date:7/29/2014)... Bryan, TX (PRWEB) July 29, 2014 ... of autonomous modular cleanrooms, today announced a new leadership ... in the United States and abroad. , Maik ... named as the company’s President charged with leading the ... , “As we enter this stage of development and ...
Breaking Biology Technology:Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 2Innovation Center @3401 Opens for Business; DreamIt Ventures and Point.io First Residents 3Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3G-CON Manufacturing, Inc. Announces Maik Jornitz as President 2
... , , COLUMBIA, Md., Dec. 16 Martek ... for the fourth quarter and fiscal year ended October 31, 2009. ... $90.4 million in the fourth quarter of fiscal 2008. Net income ... quarter of fiscal 2009, a 5% increase compared with $10.5 million, ...
... , , LAS VEGAS, Dec. 16 Cord Blood America, Inc. ... company ( http://www.cordblood-america.com ) focused on bringing the life saving ... and internationally, said today that it has reduced its debt by ... of 2009 and total debt eliminated for the year now tops ...
... , , ... Inc. (Nasdaq: SQNM ), today announced the appointment of Dr. ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO ) , Kenneth F. Buechler, ... From 1988 to 1994, Dr. Buechler was Biosite,s director of chemistry. ...
Cached Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3
(Date:7/29/2014)... fascinating journey to the edge of science, Clment Vidal ... The Beginning and the End: Does our universe have ... Are we alone in the universe? What is the ... Grounded in science and committed to philosophical rigor, the ... intelligent life is not an accident, but may well ...
(Date:7/29/2014)... comes to technology, healthcare is usually one of the last industries ... comes to wearables, healthcare is trying to move ahead of the ... and its wearable cousins is less than mature, these devices are ... in the hospital for a major procedure or for personal use ... mind, InformationWeek editor Rodney Brown set out to ...
(Date:7/29/2014)... personal genetics company, has received from the National ... for a two-year project to support the further ... for genetic discovery. , Specifically, the grant ... of web-based surveys to improve the company,s ability ... of survey tools to support the collection of ...
Breaking Biology News(10 mins):Book: 'The Beginning and the End' 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 223andMe scientists receive approximately $1.4 million in funding from National Institutes of Health 3
... found that the number of pests and disease outbreaks in ... The review "The consequences of Tree Pests and ... Southampton, Cambridge, Oxford and St Andrews is published today (15 ... shows that the experience of widespread death of trees, similar ...
... Clinic Lerner Research Institute have discovered recent genetic mutations ... of malaria annuallychanges that may render tens of millions ... infection. Peter A. Zimmerman, professor of international health, ... of Medicine, and David Serre, a scientific staff member ...
... , Nov. 14, 2013 Wake Forest Baptist Medical ... first-of-its-kind strategic affiliation agreement in the Triad with Cornerstone ... Cornerstone Health Enablement Strategic Solutions, LLC (CHESS). ... both partners for new models of health care delivery ...
Cached Biology News:Rising concerns over tree pests and diseases 2Vivax malaria may be evolving around natural defense 2Vivax malaria may be evolving around natural defense 3Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation 2Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation 3
... The Bio-Plex suspension array system, 100-240 V, ... for simultaneous quantitative analysis of up to ... microplate well. The suspension array is composed ... each of which may be conjugated with ...
...
... Disposable. Virgin, optically clear polystyrene with ... alphanumeric coordinates for cell counting. 100% ... is a new product number, created ... If showing no availability yet, please ...
... 100 IS System is a compact analysis system ... lasers, optics, fluidics, a controller, advanced digital signal ... compact lab analysis system includes the Luminex 100, ... has a DMF file at the FDA, and ...
Biology Products: